GOLDMAN SACHS GROUP INC - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 69 filers reported holding CIDARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$50,745
+12.8%
67,097
-7.3%
0.00%
Q3 2022$45,000
+18.4%
72,391
-7.9%
0.00%
Q2 2022$38,000
-39.7%
78,562
+4.4%
0.00%
Q1 2022$63,000
-34.4%
75,273
-0.5%
0.00%
Q4 2021$96,000
-61.0%
75,674
-31.1%
0.00%
Q3 2021$246,000
-8.2%
109,894
-17.2%
0.00%
Q2 2021$268,000
-36.9%
132,674
-16.8%
0.00%
Q1 2021$425,000
+333.7%
159,459
+225.4%
0.00%
Q4 2020$98,000
-82.3%
49,004
-74.7%
0.00%
Q3 2020$553,000
+216.0%
193,829
+308.3%
0.00%
Q2 2020$175,000
+17.4%
47,473
-21.2%
0.00%
Q1 2020$149,000
-34.6%
60,253
+1.7%
0.00%
Q4 2019$228,000
+47.1%
59,260
-23.6%
0.00%
Q3 2019$155,000
+31.4%
77,549
+10.0%
0.00%
Q2 2019$118,000
-36.2%
70,501
+0.9%
0.00%
Q1 2019$185,000
-11.1%
69,900
-21.1%
0.00%
Q4 2018$208,000
-55.1%
88,616
-15.8%
0.00%
Q3 2018$463,000
-11.6%
105,285
+4.4%
0.00%
Q2 2018$524,000
+28.1%
100,849
-1.3%
0.00%
Q1 2018$409,000
-37.1%
102,182
+17.9%
0.00%
Q2 2017$650,000
+519.0%
86,646
+748.6%
0.00%
Q2 2016$105,000
-97.0%
10,211
-96.3%
0.00%
-100.0%
Q1 2016$3,488,000
-62.8%
274,629
-49.7%
0.00%
-66.7%
Q4 2015$9,366,000
+122.2%
545,804
+64.7%
0.00%
+200.0%
Q3 2015$4,216,000
-8.1%
331,472
+1.3%
0.00%0.0%
Q2 2015$4,586,000327,1240.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,677,194$819,0001.02%
BVF INC/IL 6,861,127$3,352,0000.16%
5AM Venture Management, LLC 1,134,511$554,0000.14%
Knott David M Jr 635,254$310,0000.13%
Nantahala Capital Management 4,819,090$2,355,0000.12%
West Family Investments, Inc. 368,910$180,0000.07%
Stonepine Capital Management, LLC 208,443$102,0000.05%
JEPPSON WEALTH MANAGEMENT, LLC 181,075$88,0000.04%
Ground Swell Capital, LLC 11,397$6,0000.01%
Point72 Asset Management, L.P. 4,200,000$2,052,0000.01%
View complete list of CIDARA THERAPEUTICS INC shareholders